Gemzar (Eli Lilly and Company)
Welcome to the PulseAid listing for the Gemzar drug offered from Eli Lilly and Company. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
| NON-PROPRIETARY NAME: | Gemcitabine hydrochloride |
| SUBSTANCE NAME: | GEMCITABINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1996-05-15 |
| END MARKETING DATE: | 0000-00-00 |
Gemzar HUMAN PRESCRIPTION DRUG Details:
| Item Description | Gemzar from Eli Lilly and Company |
| LABELER NAME: | Eli Lilly and Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/5mL) |
| START MARKETING DATE: | 1996-05-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0002-7501_ca20741b-2f42-40f2-90a7-7cb9e4ed22e0 |
| PRODUCT NDC: | 0002-7501 |
| APPLICATION NUMBER: | NDA020509 |
Other GEMCITABINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
